GLEN ALLEN, Va., July 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Clearmind Medicine announced the filing of a new international patent application under the Patent Cooperation Treaty, PCT. The application covers its innovative combination therapy of MEAI and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback